CLC Bio has announced that it is collaborating with Imagenes to better support the fast-growing German market of high-throughput sequencing analyses.
Imagenes will provide all customers receiving next-generation sequencing data with a temporary license for CLC Genomics Workbench for assembly and downstream sequence analyses.
'We have been looking for a software platform that we could use to present our research results to our customers in an easy, coherent and user-friendly way,' said Dr Steffen Hennig, director of bioinformatics and services at Imagenes.
'We wanted the solution to be platform independent in the sense that our customers are running all the different next-generation sequencing instruments that are on the market,' he added.
The collaboration means that Imagenes will provide its customers with research results in CLC Bio's format, enabling them to view and post process the data further, using CLC Bio's software platform.
